|
|
 |
|
|
|
|
| Your Result on : Balance Sheet |
|
|
|
|
| Cohance Lifesciences Ltd |
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
|
|
|
|
| Book Value (Rs) |
|
| 60.8611266 |
|
|
|
|
|
|
Market Cap
(Rs In Cr.) |
|
| 37,507 |
|
|
|
|
|
|
|
|
|
|
|
|
| Year |
High (Rs) |
Low (Rs) |
Close (Rs) |
P/E High |
P/E Low |
P/E Close |
Mkt Cap.
(Rs In Cr.) |
| Jul 2025 |
1,121.15 |
935.00 |
997.50 |
161.57 |
123.14 |
140.15 |
38,161.07 |
| Jun 2025 |
1,086.95 |
931.75 |
966.65 |
157.38 |
129.21 |
135.81 |
36,980.85 |
| May 2025 |
1,179.95 |
1,007.00 |
1,044.75 |
179.28 |
132.81 |
146.79 |
39,968.70 |
| Apr 2025 |
1,246.85 |
953.05 |
1,134.40 |
117.87 |
80.65 |
106.06 |
28,877.85 |
| Mar 2025 |
1,224.00 |
1,076.35 |
1,159.80 |
119.31 |
97.28 |
108.43 |
29,524.44 |
| Feb 2025 |
1,328.20 |
1,026.00 |
1,215.10 |
136.24 |
94.11 |
113.60 |
30,932.19 |
| Jan 2025 |
1,136.75 |
929.00 |
1,055.55 |
109.25 |
82.65 |
98.68 |
26,870.60 |
| Share Prices Of
2024
|
| Dec 2024 |
1,359.00 |
1,041.10 |
1,136.00 |
132.01 |
88.73 |
106.21 |
28,918.58 |
| Nov 2024 |
1,358.75 |
1,197.35 |
1,303.85 |
130.23 |
111.35 |
121.90 |
33,191.45 |
| Oct 2024 |
1,324.00 |
1,140.50 |
1,315.50 |
124.58 |
104.93 |
122.99 |
33,488.02 |
| Sep 2024 |
1,289.30 |
1,058.35 |
1,173.35 |
124.40 |
96.76 |
109.70 |
29,869.38 |
| Aug 2024 |
1,114.00 |
921.50 |
1,079.65 |
109.00 |
77.79 |
100.94 |
27,484.11 |
| Jul 2024 |
1,070.00 |
789.10 |
997.35 |
107.32 |
73.13 |
93.24 |
25,389.04 |
| Jun 2024 |
813.00 |
597.00 |
803.75 |
76.88 |
53.87 |
75.14 |
20,460.66 |
| May 2024 |
675.60 |
601.00 |
622.70 |
64.36 |
50.93 |
58.22 |
15,851.76 |
| Apr 2024 |
687.15 |
608.35 |
658.05 |
65.85 |
55.01 |
61.52 |
16,751.65 |
| Mar 2024 |
730.95 |
599.55 |
676.60 |
71.64 |
54.33 |
63.26 |
17,223.86 |
| Feb 2024 |
693.70 |
586.10 |
630.90 |
43.23 |
33.84 |
38.05 |
16,060.50 |
| Jan 2024 |
767.00 |
651.15 |
670.45 |
47.25 |
38.32 |
40.44 |
17,067.31 |
| Share Prices Of
2023
|
| Dec 2023 |
729.65 |
655.80 |
726.15 |
44.22 |
38.92 |
43.80 |
18,485.23 |
|
| PREV |
NEXT
|
|
|
|
|
|
|
|
|
|